个人简述:

1986年毕业于中国药科大学，留校任教30年，一直工作在教学科研第一线，先后讲授了药物化学、药物合成反应、药物分子设计、药学英语、专业英语等课程。协助指导和独立指导过博士、硕士研究生50余名。在国内外期刊发表论文100余篇，其中SCI论文80余篇；申请国内外发明专利20余项，授权14项；参编著作10部。获得“教书育人”优秀教师奖；教育部优秀青年教师；国家科技部优秀论文二等奖；广东省科学技术奖励一等奖；中国药科大学先进科技工作者等荣誉。 担任国家863计划评审专家、国家自然科学基金评审专家、农业部兽药审评、江苏省新药审评专家；担任Journal of Medicinal Chemistry, Current Medicinal Chemistry，European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry等国际杂志特约审稿人。

科研工作:

科研项目：负责承担了十一五“重大新药创制”、国家自然科学基金、国家科技支撑计划、教育部科学技术研究重点项目、高等学校博士学科点专项科研基金、长三角科技攻关、江苏省自然科学基金、江苏省医药科技攻关等国家和省部级项目的研究。
近期代表性SCI论文
(1) Jie Liu, HaoRen, Jinyi Xu*, RenrenBai, Qi Yan, Wenlong Huang, Xiaoming Wu*, Jihua Fu, Qiujuan Wang, Qian Wu, Rong Fu. Total synthesis and antihypertensive activity of 7,8-dihydroxy-3-methyl-isochromanone-4. Bioorg.& Med. Chem. Lett., 2009, 19: 1822-1824.(IF 2.661)(2) Lei Wang,Dahong Li, Yihua Zhang*, Jinyi Xu*. Recent progress in the development of natural ent-kauranediterpenoids with anti-tumor activity. Mini-Rev. Med. Chem. 2011, 11, 910-919. (IF 2.528)(3) Chao Lei Wang, Bing-Feng Sun*, Shu-Guang Chen, Rui Ding, Guo-Qiang Lin*, Jinyi Xu*, Yong-Jia Shang.Concise Formal Synthesis of (+)-Englerin A and Total Synthesis of (–)-Orientalol F: Establishment of the Stereochemistry of the Organocatalytic [4+3]-Cycloaddition Reaction. Synlett, 2012, 23, 263–266. (IF 2.710)(4) Fei Sun, Peiqing Zhu, Hequan Yao, Xiaoming Wu*, Jinyi Xu*. A partial synthesis of 23-hydroxybetulonic acid and 23-hydroxybetulinic acid starting from betulinic acid. J. Chem. Res., 2012, 36(5): 254-257. (IF 0.921)(5) Renren Bai, Xue Yang, Yao Zhu, Zhiwen Zhou, WeijiaXie, Hequan Yao, Jieyun Jiang, Jie Liu*, MingqinShen, Xiaoming Wu, Jinyi Xu*. Novel nitric oxide-releasing isochroman-4-one derivatives: Synthesis and evaluation of antihypertensive activity. Bioorg.& Med. Chem., 2012, 20 (23): 6848-6855. (IF 2.921)(6) Renren Bai, Zhen Wei, Jie Liu, WeijiaXie, Hequan Yao, Xiaoming Wu*, Jieyun Jiang, Qiujuan Wang and Jinyi Xu*. Synthesis and biological evaluation of 4′-[(benzimidazole-1-yl)methyl] biphenyl-2-sulfonamide derivatives as dual angiotensin II/endothelin A receptor antagonists. Bioorg.& Med. Chem., 2012, 20 (15): 4661-4667. (IF 2.921)